Paris and Boston, March 17, 2026 – 5:45 p.m. CET – Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announces the update of its financial calendar for the 2026 fiscal year.
| Events | Date |
| Q1 2026 Sales | April 15, 2026 |
| 2025 Annual Results | April 22, 2026 |
| 2026 Annual General Meeting | June 4, 2026 |
| Q2 2026 Sales | July 21, 2026 |
| 2026 Half-Year Results | October 8, 2026 |
| Q3 2026 Sales | October 20, 2026 |
Note: These dates are indicative and subject to adjustment.
